Benjamin Moore
About Benjamin Moore
Benjamin Moore is an Associate Director at Travere Therapeutics, with a background in chemistry and extensive experience in the pharmaceutical industry. He has held positions at Genentech and Watson Pharmaceuticals, and he earned both his Bachelor's and PhD in Chemistry from the University of California system.
Work at Travere Therapeutics
Benjamin Moore serves as Associate Director at Travere Therapeutics, a position he has held since 2021. In this role, he contributes to the company's mission of developing innovative therapies for patients with rare diseases. His responsibilities include overseeing research initiatives and collaborating with cross-functional teams to advance therapeutic projects.
Previous Experience at Genentech
Prior to his current role, Benjamin Moore worked at Genentech as a Scientist from 2013 to 2021. During his eight years at the company, he engaged in various research projects aimed at drug development. His experience at Genentech provided him with a strong foundation in the biotechnology sector.
Research Background at University of California, Riverside
Benjamin Moore was a Graduate Student Researcher at the University of California, Riverside from 2007 to 2013. His research focused on chemistry, contributing to his advanced knowledge and expertise in the field. This experience helped him develop critical analytical and problem-solving skills applicable in his later roles.
Education and Academic Qualifications
Benjamin Moore earned his Bachelor of Science degree in Chemistry from the University of California, Irvine, where he studied from 2001 to 2006. He later pursued a PhD in Chemistry at the University of California, Riverside, completing his studies from 2007 to 2013. His academic background laid the groundwork for his career in scientific research and development.
Early Career at Watson Pharmaceuticals
Before his tenure at the University of California, Riverside, Benjamin Moore worked as a Chemist I at Watson Pharmaceuticals for one year from 2006 to 2007. This early experience in the pharmaceutical industry provided him with practical skills and insights into the chemistry involved in drug formulation.